STOCK-BASED COMPENSATION (Tables)

12 Months Ended

Dec. 31, 2013

STOCK-BASED COMPENSATION

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

	2013
Expected option life (years)	6.25
Risk-free interest rate	1.72	%
Expected stock price volatility	55.0	%
Dividend yield	—

Schedule of Share-based Compensation, Stock Options, Activity

(in thousands, except per share data)	Option Shares	Weighted Average Exercise Price		Weighted Average Remaining Term	Aggregate Intrinsic Value
Outstanding December 31, 2011	18	$	11.00	6.2	$	0
Granted	-		-
Exercised	-		-			0
Forfeited or expired	(18)	$	11.00
Outstanding December 31, 2012	-		-	-	$	—
Exercisable at December 31, 2012	-		-	-	$	—
Vested or expected to vest at December 31, 2012	-		-	-	$	—
Net BioSante Stock Options assumed	99	$	59.59
Granted	21	$	6.36
Exercised	-		-			—
Forfeited or expired	-		-
Outstanding December 31, 2013	120	$	50.35	2.4	$	81
Exercisable at December 31, 2013	99	$	59.59	0.9	$	—
Vested or expected to vest at December 31, 2013	120	$	50.35	2.4	$	81

Schedule of Unvested Restricted Stock Units Roll Forward

A summary of RSA activity under the Plan during the year ended December 31, 2013 is presented below:

(in thousands, except per share data)	Shares	Weighted Average Grant  Date Fair Value		Weighted Average Remaining Term (years)
Unvested at December 31, 2012	-	$	-
Granted	50	$	10.20
Vested	-	$	-
Forfeited	-	$	-
Unvested at December 31, 2013	50	$	10.20	2.84